Original articleEfficacy and safety of a novel topical minocycline foam for the treatment of moderate to severe acne vulgaris: A phase 3 study
Under a Creative Commons license
open access
Key words
acne vulgaris
clinical study
efficacy
foam
minocycline
randomized
safety
topical administration
Abbreviations used
AV
acne vulgaris
CI
confidence interval
CK
creatine phosphokinase
IGA
Investigator's Global Assessment
LSM
least squares mean
TEAE
treatment-emergent adverse event
AE
adverse event
ITT
intent to treat
Cited by (0)
Funding sources: Sponsored by Foamix Pharmaceuticals, Inc.
Disclosure: Drs Raoof, Hooper, Zaiac, Sullivan, Lain, and Moore served as investigators for Foamix Pharmaceuticals. Dr Kircik is an investigator and consultant for Foamix Pharmaceuticals. Dr Jankicevic is a consultant for Foamix Pharmaceuticals. Dr Stuart is an employee and stockholder at Foamix Pharmaceuticals.
© 2019 by the American Academy of Dermatology, Inc. Published by Elsevier Inc.